Through high throughput screening (HTS), the O’Malley group identified bufalin as a potent proof-of-concept SRC-3 small molecule inhibitor (SMI). Our group developed bufalin nanoparticles to reduce ...
PLoS One. 2014; 9(4):e95243. PMID: 24743578. Wang Y, Lonard DM, Yu Y, et al. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1. Cancer Res. 2014 Mar 01; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback